Retraction of ‘Berberine alleviates amyloid beta-induced injury in Alzheimer’s disease by miR-107/ZNF217’ by Jing Wang et al., RSC Adv., 2019, 9, 25232–25239, DOI: 10.1039/C9RA04500G.